Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt

“Introduction of the competition is the best way to lower the prices. Patent protection is the major barrier to the generic production of these medicines,” SJM said in a statement Sunday, proposing the government to use the public health safeguards in the Patents Act and permit more companies to produce these medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tklxoZ
via IFTTT